Elanco Animal Health Inc SEC filings ELAN
Elanco Animal Health Inc has 1,015 filings in SEC EDGAR's recent list, going back to Sep 19, 2018. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2025 | — |
| DEF 14A | Proxy statement | Mar 27, 2025 | May 16, 2025 |
| DEFA14A | Additional proxy material | Apr 19, 2024 | — |
| DEF 14A | Proxy statement | Apr 19, 2024 | May 30, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 8, 2024 | May 30, 2024 |
| DEFA14A | Additional proxy material | Feb 29, 2024 | — |
| DEFA14A | Additional proxy material | Feb 29, 2024 | — |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | — |
| DEFA14A | Additional proxy material | Apr 6, 2022 | — |
| DEF 14A | Proxy statement | Apr 6, 2022 | May 18, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 24, 2022 | May 18, 2022 |
| DEFA14A | Additional proxy material | Apr 8, 2021 | — |
| DEF 14A | Proxy statement | Mar 25, 2021 | May 19, 2021 |
| DEFA14A | Additional proxy material | Apr 8, 2020 | — |
| DEF 14A | Proxy statement | Apr 8, 2020 | May 21, 2020 |
| DEF 14A | Proxy statement | Apr 3, 2019 | May 8, 2019 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELAN (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1739104
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.